Table 2: Clinical
Characteristics and Patient Outcomes.
Case |
Sex |
Age |
BMI |
Presentation |
MH |
Affected artery |
Type |
Ivus |
Intervention |
Ef By eco or Vtg |
Ef follow up by Eco or
gated-SPECT |
Follow up |
Recurrence syntoms |
CE: CD/SCD/TVR/TLR/MI/UA |
1 |
F |
28 |
25.3 |
STEMI |
DLP-OC |
ADA p +
FirstDia |
3 |
Yes |
PTCA + DES |
39% |
58% |
6 years
Good |
4 years
later |
0 |
2 |
F |
35 |
28 |
STEMI |
Preeclampsia-Smoke |
RCA p |
1 |
No |
PTCA + BMS |
55% |
60% |
6 years
Good |
2 Month
and 2 years later |
0 |
3 |
F |
34 |
24 |
NSTEMI |
FMD-DLP-HRT-Lacta |
LM-ADA-CX-RCA |
1 |
No |
CABG |
44% |
56% |
2 years
Good |
No |
0 |
4 |
F |
56 |
27 |
STEMI/Sy |
DLP-DVT |
ADA m d |
2 |
No |
MT |
55% |
55% |
2 years
Good |
No |
0 |
5 |
F |
44 |
27 |
STEMI/CA |
HRT |
LM-ADA |
1 |
No |
MT |
48% |
57% |
1 years
Good |
No |
0 |
6 |
M |
53 |
23 |
STEMI |
Cocaine |
ADA p m |
1 |
Yes |
MT |
40% |
40% |
1 years
Good |
1 Month
later |
0 |
ADA: Anterior Descending Artery,
Age: Years at admission, BMI: Body Mass Index, BMS: Bare Metal Stent, CA:
Cardiac Arrest, CABG: Coronary Artery Bypass Grafting, CE: Cardiac Events, CD:
Cardiac Death, CX: Circumflex, D: Distal, DES: Drug-Eluting Stent, Dia:
Diagonal, DLP: Dyslipaemia; DVP: Deep Venous Thrombosis, EF: Ejection Fraction
at Discharge, F: Female, FMD: Fibromuscular Dysplasia, Gated-Spect: Single
Photon Emission Computed Tomography, HRT: Hormone Replacement Therapy, IVUS:
Intravascular Ultrasound, Lacta: Lactation, LM: Left Main, M: Male, M: Median,
MI: Miocardail Infarction, MH: Medical History, MT: Medical Treatment, OC: Oral
Contraceptives, P: Proximal, PTCA: Percutaneous Transluminal Coronary
Angioplasty, RCA: Right Coronary Artery, STEMI: ST-segment Elevation Myocardial
Infarction, NSTEMI: Non–ST-segment Elevation Myocardial Infarction, SCD: Sudden
Cardiac Death, Sy: Syncope, TLR: Target Lesion Revascularization, TVR: Target
Vessel Revascularization, UA: Unstable Angina, Vtg: Ventriculography